+331.8%
FAST vs MRNA
+521.0%
-189.2%
-30.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.5% | +0.7% | -0.3% | +0.4% |
| 7D | -0.4% | -8.2% | +7.8% | -0.2% |
| 30D | -6.4% | +125.6% | -132.0% | -10.8% |
| 3M | +7.1% | +197.1% | -190.0% | +0.3% |
| 6M | +7.0% | +148.5% | -141.5% | +1.0% |
| YTD | +24.1% | +363.3% | -339.1% | +13.3% |
| 1Y | +4.4% | +462.0% | -457.6% | -5.9% |
| 3Y | +93.2% | +26.9% | +66.3% | +83.4% |
| 5Y | +106.4% | -69.6% | +176.0% | +99.9% |
| All | +331.8% | +521.0% | -189.2% | +282.0% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling